|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||48.68 - 49.17|
|52 Week Range||37.38 - 51.13|
|PE Ratio (TTM)||50.72|
|Earnings Date||Oct 17, 2017 - Oct 23, 2017|
|Dividend & Yield||1.06 (2.15%)|
|1y Target Est||54.94|
Abbott Laboratories' (ABT) collaboration with North West London Pathology to strengthen its steadily growing diagnostics arm.
LONDON, Aug. 15, 2017 /PRNewswire/ -- North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott (ABT) announced today that they signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott's Alinity™ ci and Alinity h series diagnostics instruments as well as their professional services and informatics solutions known as AlinIQ. The contract was the subject of a detailed and competitive procurement process conducted by NWLP.
Overview of markets and stocks